Nocturnal desaturation predicts mortality in immune-mediated ILDs
G. Margaritopoulos (London, United Kingdom), A. Proklou (Heraklio, Greece), D. Badenes Bonet (Barcelona, Spain), F. Chua (London, United Kingdom), P. George (London, United Kingdom), M. Kokosi (London, United Kingdom), V. Kouranos (London, United Kingdom), E. Renzoni (London, United Kingdom), K. Antoniou (Heraklio, Greece), A. Wells (London, United Kingdom)
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Margaritopoulos (London, United Kingdom), A. Proklou (Heraklio, Greece), D. Badenes Bonet (Barcelona, Spain), F. Chua (London, United Kingdom), P. George (London, United Kingdom), M. Kokosi (London, United Kingdom), V. Kouranos (London, United Kingdom), E. Renzoni (London, United Kingdom), K. Antoniou (Heraklio, Greece), A. Wells (London, United Kingdom). Nocturnal desaturation predicts mortality in immune-mediated ILDs. 5196
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: